EXPE Financial Statements & Analysis
Complete financial statements for EXPE including income statement, balance sheet, and cash flow statement. Analyze EXPE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
61
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
6.6% ↑
Net Income
54.8% ↑
Gross Margin
2.0% ↑
Operating Margin
19.7% ↑
Balance Sheet
Current Ratio
-7.9% ↓
Debt to Equity
-1.1% ↑
Asset Turnover
3.1% ↑
Cash Flow
Operating Cash Flow
14.7% ↑
Net Cash Flow
54.2% ↑
Free Cash Flow
26.3% ↑
Cash Flow to Debt
14.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 12.84B | 13.69B | 6.6% | |
| Gross Profit | 11.27B | 12.25B | 8.7% | |
| Operating Income | 1.03B | 1.32B | 27.7% | |
| Net Income | 797.00M | 1.23B | 54.8% | |
| EPS | 5.5 | 9.39 | 70.7% | |
| EBITDA | 2.07B | 2.63B | 26.9% | |
| Gross Margin | 87.75% | 89.46% | 2.0% | |
| Operating Margin | 8.05% | 9.63% | 19.7% | |
| Net Income Margin | 6.21% | 9.01% | 45.2% | |
| R&D Expenses | 1.36B | 1.31B | 3.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 13.69B | 12.84B | 11.67B | 8.60B | 5.20B |
| Gross Profit | 12.25B | 11.27B | 10.01B | 7.08B | 3.52B |
| Operating Income | 1.32B | 1.03B | 1.08B | 186.00M | -1527000000 |
| Net Income | 1.23B | 797.00M | 352.00M | 12.00M | -2612000000 |
| EPS | 9.39 | 5.5 | 2.25 | -1.8 | -19 |
| EBITDA | 2.63B | 2.07B | 1.61B | 1.13B | -1898000000 |
| Gross Margin | 89.46% | 87.75% | 85.80% | 82.30% | 67.69% |
| Operating Margin | 9.63% | 8.05% | 9.30% | 2.16% | -29.37% |
| Net Income Margin | 9.01% | 6.21% | 3.02% | 0.14% | -50.24% |
| R&D Expenses | 1.31B | 1.36B | 1.18B | 1.07B | 1.01B |